Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if VTVT is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
14 top institutions tracked
Last 13F trend: distributing (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 1
44 filers reported a long position in VTVT for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Samsara BioCapital, LLC | $11.2M | 298.5K | Unchanged |
| MILLENNIUM MANAGEMENT LLC | $10.2M | 269.9K | +30.8% |
| FMR LLC | $9.8M | 260.4K | Unchanged |
| Siren, L.L.C. | $6.1M | 163K | Unchanged |
| BAKER BROS. ADVISORS LP | $5.6M | 148.3K | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $3.6M | 94.5K | -13.3% |
| Trails Edge Capital Partners, LP | $3.2M | 85.2K | -39% |
| Aisling Capital Management LP | $1.9M | 50K | New |
| MARSHALL WACE, LLP | $1.5M | 39.6K | +195.5% |
| GEODE CAPITAL MANAGEMENT, LLC | $1.2M | 32.5K | -1.3% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.